Saturday, 04 February 2012

  • Starting from scratch: Would you put it all on the line to build a new life in business?
  • How a sleepy town north of Auckland became a centre of marine innovation
  • Deal maker Sebastian Stapleton's bootstrapping success story
Subscribe

Follow the money

The moratorium on GM release is scheduled to end in October. That's great news for our "clean green" farming economy, right? "No," says Simon Terry. "Yes," says Francis Wevers. They put their cases

Monday, May 26 2003 || BY Simon Terry and Francis Wevers

Whatever benefits GM technology adds to farm production will be ruined by massive resistance to trade, reckons Simon Terry

New Zealand has much more at stake than any other nation in considering GM food production. Half of our export income, some $16 billion a year, is derived from primary production. This is five times the OECD average of 10%. In other words, the stakes are five times higher than average for New Zealand.

Even if New Zealand was fairly sure GM food would eventually provide economic benefits, is it smart to commit to this track now? The commercial prospects for GM food hinge not on proof of the science, but on consumer preferences. It is the choices made by importers and retailers in Europe and Japan that define the economics of GM food. The decision is also largely irreversible. Once a commitment has been made to large-scale GM plantings, there is essentially no going back.

In the wake of a series of food scandals including mad cow disease, educated and affluent consumers in Europe and the Far East increasingly want “safe” food. “A majority of Europeans do not support GM foods. These are judged not to be useful and to be risky for society,” the European Commission reported in its latest official survey in March. Already a group of major European supermarket chains and food processors have rejected GM foods, forming a consortium to source non-GM ingredients.

In April the New Zealand government released a study examining the economics of GM release for New Zealand and it begins to quantify what is at stake. Business and Economic Research Limited found that “20% to 30% [of consumers in major export markets] state they would cease purchasing New Zealand commodities if New Zealand released GMOs”. When these levels of market rejection were fed into economic models, BERL observed that additional productivity gains from GM would need to be considerably above historical levels over a decade to offset the effect of the market downturn. In the dairy and meat industries for example, even an additional 2.5% per annum gain in productivity from GM (versus an historical 1% per annum) was not quite sufficient to stave off a decline in GDP for the economy as a whole.

The results were even starker for farm incomes. The report stated for the dairy, meat and horticulture industries, while a 20% drop in sales would result in producer incomes falling 43%, should GM deliver a similar percentage rise in output, the overall income gain is just 5%. In consequence, the study observed that pursuing additional sales was a better strategy than seeking productivity gains through GM release.

The proposed release of GM wheat has further spelt out the market risks. Existing GM food production has largely ducked market resistance by being refined into products that escape current labelling requirements or by being fed to animals — though even feed is now coming under threat. But wheat is quite different. Unlike corn, soy and maize — the principal GM crops now grown — wheat is predominantly destined for human consumption. So what’s happening with GM wheat? When North American wheat exporters consulted their major buyers as to the acceptability of GM wheat, the responses were clear cut across Europe and Asia. Not only was there near universal refusal to take any GM wheat, many stated they would reject shipments that contained even trace GM contamination — including all Japanese importers surveyed where Japan is the biggest purchaser. Comments from the buyers to US Wheat Associates were stark. “The European milling industry will simply not buy one more kilo of any US wheat at all if GM wheat is commercialised,” said Grand Molini, the largest miller in Italy.

These responses highlight the real scope of the GM food issue. The risk is not that a minority of farmers decides to go GM and lose their markets. It is that if some go GM, then all farmers of similar produce are affected. For example, while only a minority of US corn production is GM, virtually all US corn exports to Europe have been lost — sales equivalent to about $US1 billion to date.

In New Zealand there has been considerable talk about how different production methods can “coexist”. However, the bottom line for North American wheat growers is that they cannot identify a system in which they would have confidence. Until they can see such a system, they are opposing the introduction of GM wheat. Similarly, the European Commission does not believe that zero contamination is possible in practice.

Advocates of GM release argue that the Environmental Risk Management Authority (ERMA) should be free to decide on a case-by-case basis if and when the first GM release takes place.

However, this approach would delegate a fundamental question of national policy and strategy to an agency that specialises simply in environmental risk. As the BERL report makes clear, GM release affects New Zealand at the country brand level — our “clean green” image. This is not readily assessed in the context of an ERMA “case-by-case” decision.

The Royal Commission on Genetic Modification recommendation that New Zealand could have it both ways was based on there being reliable means to keep GM and non-GM production apart. The Commission’s major recommendation that New Zealand “preserve opportunities” requires that non-GM food producers are able to deliver GM free food.

As noted above, it is markets that set the standards for what is GM free and these are intolerant of contamination. In absence of identified means to prevent cross-contamination, a decision to allow large-scale commercial release would remove the opportunity for non-GM farmers of like varieties to meet market demand for GM-free product. This is especially significant when only 22% of farmers say they intend to use GM technology in the next ten years.

There is no obvious demand for uptake of the existing GMO varieties by New Zealand farmers in the near future. “New Zealand grain growers see little of value for them in the current range of modified crops,” Federated Farmers has stated. New GM products of significance are five to ten years away from commercialisation.

So why open the gates to GM release now? Why not wait and see what emerges that could offer economic benefits when consumer responses are taken into account? Why relinquish New Zealand’s highly marketable status as a GM-free food producer at this time?

At least until the minimum economic conditions for GM release are satisfied, there is every reason for New Zealand to retain its status as GM-free food producer.

Simon Terry is executive director of the Sustainability Council of New Zealand, a group advocating New Zealand retain its status as a GM-free food producer.

If we planted GM ryegrass
A recent BERL report hypothesised the release of a theoretical GM ryegrass for use as feed to dairy and meat industries. Assuming significant productivity gains were possible and exclusive to New Zealand, it asks how these gains, combined with a consumer backlash to GM foods, would affect farm incomes. Using a Lincoln University economic model that simulates each of the key dynamics in international trade, the results show that should GM grass prove capable of delivering major productivity gains, the benefits from this would largely be offset by falling prices.

Productivity increase
FALL IN DEMAND
None
25% increase
40% increase
60% increase
None
0.8%
5.1%
8.1%
10.5%
20% discount for all New Zealand meat, dairy and fruit
-43.3%
-
-
-

The end of the GM moratorium
Commercial release of GM organisms is not only safe, it is key to our competitiveness, argues Francis Wevers

While I’m certainly no fan of the Sustainability Council’s arguments, it is one of the few organisations to focus attention on some important aspects of GM release into the environment. You see its arguments above, but essentially, they boil down to these: are GMOs safe enough to release? And will limiting their release overly damage our agricultural economy? Good questions to be sure. But SCONZ has failed to provide the answers which justify its calls for a further moratorium of five years on commercial release.

Take the science. Here the debate is settled, or on the way to being settled. A formidable review by scientists Tony Conner (of Crop & Food), Travis Glare (AgResearch) and Jan-Peiter Nap (Plant Research International, Wageningen, The Netherlands) of 250 peer-reviewed published papers on the environmental impacts of currently released GM crops, shows quite clearly that when compared with their non-GM counterparts, GM crops pose no new hazards to the environment. The review was performed for The Plant Journal, one of the most prestigious plant science publications globally.

There’s still some interesting scientific inquiry to be completed by a broad-based New Zealand team into the consequences of horizontal gene transfer in the soil but all the early indications show the introduction of transgenes doesn’t pose any new problems. And research completed in Australia on canola by Mary Reiger, Rick Roush and their colleagues at the Weed Cooperative Research centre at Adelaide University shows the consequences of pollen-mediated horizontal gene transfer to be almost undetectable at separation distances of 100 metres.

So a key question for the select committee (about the ability of GM crops to co-exist with non-GM agriculture) is being resolved by the science. Of course, it’s not the committee’s job to settle this question — its task is to make sure the regulator, in this case ERMA, is equipped with the tools to consider the scientific issues. The proposal to give ERMA the power to impose conditions on release addresses any potential gap between existing scientific knowledge and the future outcomes of ongoing research and monitoring programmes.

But the existing science offers quite a lot of certainty. Numerous studies, which have been accepted by regulators in the US, Australia and Europe, substantiate claims that the currently approved use of GM technology is safe. These studies come from reputable, independent, scientists and can be found in many reputable peer-reviewed journals. In addition the World Health Organisation, Food and Agriculture Organisation and many international science organisations have concluded that the foods derived from current GM crops are as safe as, if not safer than, their conventional or organic counterparts. You can find more of all this science by following up the references on the web version of this story or checking out the website.

Another key piece of information for the select committee is the economic impact of GM. Just before Easter, the government released two of the final pieces in the jigsaw. An economic impacts study (undertaken in part by anti-GM ­academics Hugh Campbell and Caroline Saunders) showed the most likely impact of a release of GM into the environment would be a small positive gain to GDP. The study scoped a number of unlikely scenarios, dismissed by Treasury in some very forthright advice to ministers, which were angrily picked up by detractors to denounce the government’s intentions to proceed. Among the less likely scenarios, but ignored by SCONZ, of course, was the conclusion that GDP would decline by over 6% if New Zealand went GM free.

One oft-quoted danger for our economy is the consumer backlash to GM food. On the face of it, the fact that European consumers have told pollsters they don’t want to eat food derived from GM makes the desirability of growing GM crops in New Zealand somewhat suspect. That’s what GE-Free NZ and the Sustainability Council would have us all believe. But that analysis is facile. Looked at another way, a 2002 EuroBarometer survey, which shows a majority preference against GM food, also shows a very healthy preference for food that has reduced pesticide residues and is environmentally more friendly — two specific claims substantiated by GM crops. An excellent study by Richard Phipps from Reading University discloses that if 50% of the UK cropping sector was GM, there would be 14.5 million kilos less pesticide active ingredient used a year; 20.5 million litres less diesel fuel (for applying pesticide) and 73,000 tonnes less carbon released into the atmosphere.

Anyway, this foo-fooing around is academic. In October, the European Parliament will lift its non-science-based moratorium on GMO imports at the same time as we lift ours on applications to commercialise. Nor have the Europeans been slow on the science — during the last few months they’ve approved dozens of releases of GMOs into their own environment for field trial purposes, which is hardly the action of fearful states. See the European Commission Joint Research Centre website to find out more.

When that happens, parliamentarians will get to another much-trumpeted but over-inflated “problem”: liability of GM contamination. I say “problem” because no one anywhere has produced an empirical basis assessing a risk profile that shows GM poses a greater risk than its conventional counterparts. Indeed, actuaries haven’t set a risk profile because there is no negative track record to work from.

The government has made it clear it expects miscreants who deliberately breach conditions laid down by ERMA to pay a heavy price. No trouble there. But this doesn’t constitute the sort of “strict liability” regime wanted by GM opponents. Under its recommendations SCONZ wants the grower/developer of a GM crop to be liable for any claim of damage without the complainant proving any damage at all. The burden of proof shifts so that the grower/developer has to prove innocence or lack of damage. Moreover, there are no costs imposed on submitters; all the costs of hearings are borne by applicants; there are no limits on what can and should be heard. Bizarre? Yes, but look closer at the ploy: the antis hope to price the science and development out of the market by imposing huge compliance costs. Even without the strict liability regime, the cost of an application fee for approval for a GM field trial in New Zealand is $5000, in the US $15 and in Australia $0.

As groups such as Federated Farmers have pointed out, New Zealand farmers and producers should be free to make rational economic decisions on what is the best product mix for them. Users will continue to be the best judges of the best New Zealand Inc response to export markets. What the scientists and developers have to do is give them the best products at the best price to keep up with the competition. This debate is nothing more than an argument over technological advantage. Imagine, for example, what the antis might have said about refrigeration — and the cost of their opposition to the New Zealand economy last century.

Francis Wevers is the executive director of the Life Sciences Network, an association of science- and research-based organisations.